Adimab Records Another Year of Double-Digit Clinical Program Growth

Adimab announces continued clinical momentum in 2025, with 11 new partner programs entering the clinic. To date, 89 Adimab-enabled programs have advanced to the clinic, with six partner programs now on the market.

Adimab Reports Strong Partnering Year for 2025

Adimab entered into 23 new partnerships, added 75 new programs, and achieved 50 milestones in 2025. To date, the company has generated more than 650 therapeutic programs.

Adimab Provides Update on Pipeline

Five therapeutic products containing molecules discovered or optimized by Adimab have been approved for commercial sale.